Condition (MeSH)
Acute-Phase Reaction
ClinicalTrials.gov lists 18 trials for Acute-Phase Reaction or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
18 of the 18 trials are tagged with Acute-Phase Reaction itself; the rest are tagged with a narrower condition beneath it.
When did Acute-Phase Reaction trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2023 | 1 |
| 2022 | 1 |
| 2021 | 3 |
| 2020 | 1 |
| 2019 | 2 |
| 2017 | 2 |
| 2014 | 1 |
| 2012 | 2 |
| 2010 | 2 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Acute-Phase Reaction trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 2 |
| Not applicable | 8 |
| Observational | 8 |
How many Acute-Phase Reaction trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Enrolling by invitation | 2 |
| Completed | 8 |
| Withdrawn | 1 |
| Unknown status | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Acute-Phase Reaction trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Hospital General de Mexico | 1 |
| Institut de Recherche pour le Developpement | 1 |
Which drugs are being tested for Acute-Phase Reaction? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Vitamin A | 1 |
Interventions as named in the registry (3)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Pravastatin Pill | 1 |
| Bortezomib SC | 1 |
| Blood Sampling | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Acute-Phase Reaction? (135)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Change in body temperature, not acute-phase reaction, predict anti-Osteoporosis efficacy after the first administration of Zoledronic acid: a prospective observational cohort study. | BMC musculoskeletal disorders | 2024 | Yes |
| Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial. | BMJ open | 2022 | Yes |
| Acute inflammatory profiles differ with sex and age after spinal cord injury. | Journal of neuroinflammation | 2021 | Yes |
| Does adding corticosteroids to periarticular injection affect the postoperative acute phase response after total knee arthroplasty? | The Knee | 2020 | Yes |
| The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer. | Immunobiology | 2018 | Yes |
Showing 5 of 135 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.